Although stereotactic radiation provides a noninvasive approach to treating acoustic neuromas, it also carries the risk of hearing loss over time for a sizable portion of patients, according to experts.
Explore this issue:May 2008
Risk of Hearing Loss
The true long-term incidence of hearing loss associated with stereotactic radiation is not known but occurs in a significant number of patients, said Douglas C. Bigelow, MD, Associate Professor in the Department of Otorhinolaryngology-Head and Neck Surgery, Co-Director of the Center for Cranial Base Surgery, and Director of the Division of Otology/Neurotology at the University of Pennsylvania in Philadelphia.
New research presented at the 2008 Triological Society Southern Section meeting in January concluded that patients with acoustic neuromas treated with stereotactic radiation have a significant decrease in auditory function over time.